Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.

Deddish PA, Wang LX, Jackman HL, Michel B, Wang J, Skidgel RA, Erdös EG.

J Pharmacol Exp Ther. 1996 Dec;279(3):1582-9.

PMID:
8968386
2.

Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.

Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F.

J Biol Chem. 1994 Oct 28;269(43):26806-14.

4.

Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.

Georgiadis D, Beau F, Czarny B, Cotton J, Yiotakis A, Dive V.

Circ Res. 2003 Jul 25;93(2):148-54. Epub 2003 Jun 12.

PMID:
12805239
5.

The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.

Wei L, Clauser E, Alhenc-Gelas F, Corvol P.

J Biol Chem. 1992 Jul 5;267(19):13398-405.

6.

Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.

Ceconi C, Francolini G, Olivares A, Comini L, Bachetti T, Ferrari R.

Eur J Pharmacol. 2007 Dec 22;577(1-3):1-6. Epub 2007 Aug 3.

PMID:
17716647
7.
8.

[Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].

Costerousse O, Jaspard E, Allegrini J, Wei L, Alhenc-Gelas F.

C R Seances Soc Biol Fil. 1992;186(6):586-98. Review. French.

PMID:
1339589
9.

Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Azizi M, Junot C, Ezan E, Ménard J.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1066-9.

PMID:
11903317
10.

Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.

Ryan JW, Valido FA, Sequeira MJ, Chung AY, Berryer P, Chen XL, Catravas JD.

J Pharmacol Exp Ther. 1994 Jul;270(1):260-8.

PMID:
8035324
11.
12.

Inhibitory effect of reactive oxygen species on angiotensin I-converting enzyme (kininase II).

Michel B, Grima M, Nirina LB, Ingert C, Coquard C, Barthelmebs M, Imbs JL.

Clin Exp Pharmacol Physiol. 2001 Mar;28(3):212-8.

PMID:
11207678
13.

The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

Wei L, Alhenc-Gelas F, Corvol P, Clauser E.

J Biol Chem. 1991 May 15;266(14):9002-8.

14.

Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.

Georgiadis D, Cuniasse P, Cotton J, Yiotakis A, Dive V.

Biochemistry. 2004 Jun 29;43(25):8048-54.

PMID:
15209500
15.

Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture.

Andrade MC, Quinto BM, Carmona AK, Ribas OS, Boim MA, Schor N, Casarini DE.

J Hypertens. 1998 Dec;16(12 Pt 2):2063-74.

PMID:
9886898
17.

Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.

Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA.

Biochemistry (Mosc). 1999 Aug;64(8):938-44.

PMID:
10498812
18.

Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.

Fuchs S, Xiao HD, Cole JM, Adams JW, Frenzel K, Michaud A, Zhao H, Keshelava G, Capecchi MR, Corvol P, Bernstein KE.

J Biol Chem. 2004 Apr 16;279(16):15946-53. Epub 2004 Feb 2.

19.
20.

N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdös EG.

Hypertension. 1998 Apr;31(4):912-7.

PMID:
9535414

Supplemental Content

Support Center